References
Nazir SA, Erbland ML. Chronic obstructive pulmonary disease: an update on diagnosis and management issues in older adults. Drugs Aging 2009; 26(10): 813–31
Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet 2007 Sep 1; 370(9589): 741–50
Parameswaran GI, Murphy TF. Chronic obstructive pulmonary disease: role of bacteria and updated guide to antibacterial selection in the older patient. Drugs Aging 2009; 26(12): 985–95
Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004 Jun; 23(6): 932–46
Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007 Sep 15; 176(6): 532–55
Miravitlles M, Murio C, Guerrero T, et al. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 2002 May; 121(5): 1449–55
Stockley RA, O’Brien C, Pye A, et al. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 2000 Jun; 117(6): 1638–45
Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005 Dec 1; 26(6): 1138–80
Eller J, Ede A, Schaberg T, et al. Infective exacerbations of chronic bronchitis. Chest 1998 Jun; 113(6): 1542–8
Blasi F, Tarsia P, Pappalettera M, et al. Antibiotic therapy and prophylaxis in COPD. Respir Med COPD Update 2007; 2(4): 124–32
Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008 Nov 27; 359(22): 2355–65
Falagas ME, Avferi SG, Matthaiou DK, et al. Short-versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis. J Antimicrob Chemother 2008 Sep; 62(3): 442–50
Aaron SD, Vandemheen KL, Hebert P, et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med 2003 Jun 26; 358(26): 2618–25
Niewoehner DE, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbation of chronic obstructive pulmonary disease: Department of Veterans Affairs Cooperative Study Group. N Engl J Med 1999 Jun 24; 340(25): 1941–7
Davies L, Angus RM, Calverley PM. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 1999 Aug 7; 354(9177): 456–60
Ram FS, Picot J, Lightowler J, et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2004; (3): CD004104
Balami JS, Packham SM, Gosney MA. Non-invasive ventilation for respiratory failure due to acute exacerbations of chronic obstrutive pulmonary disease in older patients. Age Ageing 2006 Jan; 35(1): 75–9
Rozzini R, Sabatini T, Trabucchi M. Non-invasive ventilation for respiratory failure in elderly patients. Age Ageing 2006 Sep; 25(5): 546–7
Rights and permissions
About this article
Cite this article
Acute exacerbations of chronic obstructive pulmonary disease in elderly patients often require treatment with antibacterials. Drugs Ther. Perspect 26, 14–16 (2010). https://doi.org/10.2165/11205250-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11205250-000000000-00000